Your browser doesn't support javascript.
loading
CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer.
Lei, Hanqi; Wang, Zifeng; Jiang, Donggen; Liu, Fang; Liu, Meiling; Lei, Xinxing; Yang, Yafei; He, Bin; Yan, Min; Huang, Hai; Liu, Quentin; Pang, Jun.
Afiliação
  • Lei H; Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Wang Z; Department of Urology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
  • Jiang D; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Liu F; Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Liu M; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Lei X; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Yang Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • He B; Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Yan M; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Huang H; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Liu Q; Department of Urology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China. huangh9@mail.sysu.edu.cn.
  • Pang J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. liuq9@mail.sysu.edu.cn.
Cell Death Dis ; 12(8): 740, 2021 07 27.
Article em En | MEDLINE | ID: mdl-34315855

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Quinases Ciclina-Dependentes / Sistemas CRISPR-Cas Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Cell Death Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Quinases Ciclina-Dependentes / Sistemas CRISPR-Cas Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Cell Death Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China